ENANTA PHARMACEUTICALS, INC Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
ENANTA PHARMACEUTICALS, INC (ENTA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.20% for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-11-19
- ENANTA PHARMACEUTICALS, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -0.20%, a 300.00% decline from fiscal 2024.
- ENANTA PHARMACEUTICALS, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 0.10%, a 80.00% decline from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 0.50%.
- ENANTA PHARMACEUTICALS, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.30%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-09-30 | -0.20% 10-K · filed 2025-11-19 | |
| 2024-09-30 | 0.10% 10-K · filed 2025-11-19 | |
| 2023-09-30 | 0.50% 10-K · filed 2025-11-19 | 0.30% 10-K · filed 2023-11-22 |
| 2022-09-30 | -0.30% 10-K · filed 2024-11-27 | |
| 2021-09-30 | 0.00% 10-K · filed 2023-11-22 | -0.80% 10-K · filed 2021-11-24 |
| 2020-09-30 | -1.70% 10-K · filed 2022-11-23 | -4.30% 10-K · filed 2020-11-25 |
| 2019-09-30 | -1.90% 10-K · filed 2021-11-24 | |
| 2018-09-30 | -0.60% 10-K · filed 2020-11-25 | |
| 2017-09-30 | -0.50% 10-K · filed 2019-11-27 | |
| 2016-09-30 | -3.00% 10-K · filed 2018-11-29 | -0.40% 10-K · filed 2016-12-09 |
| 2015-09-30 | -1.30% 10-K · filed 2017-12-11 | -0.80% 10-K · filed 2015-12-11 |
| 2014-09-30 | 2.20% 10-K · filed 2016-12-09 | |
| 2013-09-30 | 14.00% 10-K · filed 2015-12-11 | |
| 2012-09-30 | 0.90% 10-K · filed 2014-12-11 | |
| 2011-09-30 | 2.70% 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |